Accellta
PrivateLast Round
Grant
Sep 1, 2025
Total Funding Raised
$500,000
Company Overview
Accellta operates in Healthcare & Life Sciences and is based in Haifa. Its latest recorded funding round was a Grant round in September 2025.
Accellta is a biotechnology company that provides stem cell culture technologies, biomanufacturing services, and cultured dairy fat solutions for the pharmaceutical, regenerative medicine, and food-tech industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Accellta Comparables
Compare Accellta with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TreeFrog Therapeutics | 79% | |
| RoosterBio | 75% | |
| WuXi AppTec | 71% |
For institutional investors. Book with your work email.
Accellta Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2025 | ||||
| VC Round | Aug 25, 2025 | ||||
| Grant | Dec 20, 2023 | ||||
| Series A | Nov 1, 2014 | ||||
| Seed | Nov 1, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Accellta Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Seed |
| AMIT Technion | Seed |
| Israel Innovation Authority | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2025
Received funding from the Israel Innovation Authority.
- Nov 1, 2014
Completed a Series A funding round.
For institutional investors. Book with your work email.
Accellta Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Accellta's valuation, stock price, and market status.
Is Accellta a public or private company?
Accellta is a private company.
What is the current stock price of Accellta?
Accellta is a private company, so its shares have no public market price. Caplight tracks Accellta's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Accellta worth (valuation)?
Valuation information for Accellta is not publicly available.
Can I buy Accellta stock?
Accellta shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Accellta's last funding round?
Accellta's most recent funding round was Grant on September 1, 2025.
Who are the main investors in Accellta?
Key investors in Accellta include Horizons Ventures, AMIT Technion, Israel Innovation Authority.
Will Accellta IPO soon?
No public IPO plans have been announced for Accellta.
How can I track Accellta secondary market activity?
Caplight tracks bids, offers, and trades in Accellta's shares on secondary markets.